Clinical trial
A Two-part, Double-blind, Placebo-controlled, Phase I Study of the Safety and Pharmacokinetics of Single Doses of GT300 in Healthy Subjects
NCT04963855 is registered in ClinicalTrials.gov with Generian Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Two-part, Double-blind, Placebo-controlled, Phase I Study of the Safety and Pharmacokinetics of Single Doses of GT300 in Healthy Subjects
- Lead sponsor
- Generian Pharmaceuticals, Inc.
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- August 23, 2021
- Completion date
- March 15, 2022
- Enrollment
- 56 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.